Integrated Phytochemical and Pharmacological Insights into Premna serratifolia for Drug Discovery: A Narrative Review.

Natural products remain a rich source of chemically diverse molecules with therapeutic potential, and Premna serratifolia represents one such promising botanical resource. This review provides a comprehensive overview of its bioactive constituents by integrating published evidence related to extraction variability, chemical profiling, physicochemical screening, and pharmacological activities. Available studies indicate that differences in extraction techniques influence the distribution of secondary metabolites, particularly phenolic and flavonoid compounds associated with biological activity. Previous phytochemical investigations have reported a structurally diverse set of compounds spanning multiple chemical classes. Evaluations based on drug-relevant parameters suggest that several constituents possess favorable structural and physicochemical characteristics. Published studies further suggest that selected compounds may interact with multiple protein targets involved in disease-related pathways. Computational evidence reported in the literature highlights potential molecular interactions and signaling networks associated with therapeutic activities. These pathways have been linked to biological processes such as cellular regulation, oxidative balance, and inflammatory responses. Available experimental evidence indicates that several compounds exhibit noteworthy bioactivities across different biological systems. Structural features, including functional group distribution and degree of substitution, have been reported to influence molecular interactions and pharmacokinetic properties. Simpler molecular frameworks often appear to show greater compatibility with drug-likeness criteria. The integration of phytochemical, pharmacological, and computational evidence provides a useful framework for compound prioritization and evaluation. Such an approach may facilitate the transition from phytochemical discovery toward pharmacological development. Further studies involving structural optimization, advanced computational modeling, and experimental validation are warranted to better characterize the therapeutic potential of these compounds. The available evidence suggests that Premna serratifolia is a valuable source of bioactive molecular scaffolds with considerable potential for future multitarget drug discovery and therapeutic development.